2017 GLOBAL FINALIST
Cresilon
Digital Health
Cresilon is a medical device company focused on hemostatic technologies that improve wound care and advance the standard of medical treatments. The company's flagship product, VETIGEL®, is a single-use, prescription hemostatic gel for veterinary use. It helps control bleeding in animals by achieving hemostasis in seconds.
💸 Select investors: Innovating Capital, Dorm Room Fund, Valued Ventures, Paulson Investment Company, Bespoke Ventures
📌 HQ: Brooklyn, New York, United States